753PPrognostic and predictive value of baseline alpha-fetoprotein (AFP) in patients with advanced hepatocellular carcinoma (HCC) treated with ramucirumab from two phase III studies (REACH, REACH-2)
Zhu, A X, Galle, P R, Llovet, J M, Finn, R S, Kang, Y-K, Yen, C J, Assenat, E, Brandi, G, Motomura, K, Ohno, I, Daniele, B, Vogel, A, Yamashita, T, Hsu, C-H, Meyer, T, Widau, R, Schelman, W, Wang, C,Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz247.079
Date:
October, 2019
File:
PDF, 93 KB
2019